BONESUPPORT HOLDING AB (publ) – Interim Report
January – September 2018Lund, Sweden, 08.00 CET, 7 November 2018 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, has published its Q3 2018 Interim Report.Successfully established new US distribution structure1 July – 30 September 2018 · Net Sales amounted to SEK 14.2 million (32.7), a decrease by 56%. As expected, there were no sales in the segment North America due to the termination of the Company’s US distribution agreement in May. The increase in the segment Europe and ROW was 29% · Gross margin of 91.0% (87.8) · Operating loss of